Dan Lü
Peking University(CN)Peking University First Hospital(CN)
Publications by Year
Research Areas
Ferroptosis and cancer prognosis, Advanced Breast Cancer Therapies, Cancer, Lipids, and Metabolism, Pulmonary Hypertension Research and Treatments, interferon and immune responses
Most-Cited Works
- → CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma(2012)192 cited
- → The phosphatase DUSP2 controls the activity of the transcription activator STAT3 and regulates TH17 differentiation(2015)154 cited
- → The deubiquitinase OTUD1 enhances iron transport and potentiates host antitumor immunity(2021)141 cited
- → Synthesizing a novel genetic sequential logic circuit: a push‐on push‐off switch(2010)130 cited
- → The phosphatase PAC1 acts as a T cell suppressor and attenuates host antitumor immunity(2020)116 cited
- → Legumain: A biomarker for diagnosis and prognosis of human ovarian cancer(2012)106 cited
- → SOX2 regulates apoptosis through MAP4K4-Survivin signaling pathway in human lung cancer cells(2013)104 cited
- → Mutations of deubiquitinase OTUD1 are associated with autoimmune disorders(2018)94 cited
- → Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma(2014)66 cited
- → Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) promotes lung tumorigenesis via attenuating p53 stability(2017)63 cited